Gynecologic Clinical Trials in Shanghai, Shanghai Municipality
8 recruitingShanghai, Shanghai Municipality, China
Showing 1–8 of 8 trials
Recruiting
Early Phase 1
Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies
Advanced Gynecological Cancers
Obstetrics & Gynecology Hospital of Fudan University20 enrolled1 locationNCT07434284
Recruiting
Early Phase 1
A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
Treatment Side EffectsEffects of ImmunotherapyAdvanced Gynecologic Tumors+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098171
Recruiting
Phase 1Phase 2
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Solid TumorGynecological Malignant Tumor
Sichuan Baili Pharmaceutical Co., Ltd.38 enrolled1 locationNCT05803018
Recruiting
Phase 2
A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced
Gynecological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.170 enrolled31 locationsNCT06798207
Recruiting
Not Applicable
A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors
Gynecological Solid Tumors
Obstetrics & Gynecology Hospital of Fudan University20 enrolled1 locationNCT06904131
Recruiting
Not Applicable
Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (gynecological Tumors)
Solid TumorGynecological Tumors
Grit Biotechnology36 enrolled1 locationNCT06145802
Recruiting
Early Phase 1
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors
Adult Gynecological Tumors
Grit Biotechnology26 enrolled1 locationNCT06834542
Recruiting
Not Applicable
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer)
AdultGynecological Tumors
Grit Biotechnology26 enrolled1 locationNCT06191900